Thus, in the present study, the effect of an NF-κB inhibitor, BAY-11–7082 (BAY), was investigated in carbon tetrachloride (CCl4)-induced mouse model of liver fibrosis. Here, NFKB1 is linked to Hepatic fibrosis.